Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-08-14

FDA Approved: CLONIDINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for clonidine from Ingenus Pharmaceuticals, LLC, resulting in updated labeling for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)

Snippet

SUPPL AP for CLONIDINE (CLONIDINE)